Metraipolis › archive › dc_3fa6532032dd

Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small… — Europe PMC PMID:41488620

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41488620
DOI: 10.3389/fimmu.2025.1686260
License (as archived): solo-consultazione
Archived: 2026-11-07T12:32:43.557Z
SHA-256 of the archived text: 3a9aa610d3e17d05e5c746de0c9be7faf38a73e3d4f64a57425a6d109750b44e
Stable URL of this page: https://metraipolis.com/documento/dc_3fa6532032dd

How to cite

Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small… — Europe PMC PMID:41488620 — Europe PMC (en), https://europepmc.org/article/MED/41488620 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fa6532032dd (Metraipolis archive dc_3fa6532032dd, sha256 3a9aa610d3e17d05e5c746de0c9be7faf38a73e3d4f64a57425a6d109750b44e)

BibTeX

@misc{dc3fa6532032dd,
  title = {Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small… — Europe PMC PMID:41488620},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41488620},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fa6532032dd; sha256 3a9aa610d3e17d05e5c746de0c9be7faf38a73e3d4f64a57425a6d109750b44e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488620. Agents can read the archived copy with the MCP tool read_document.